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Jarvik et al., p. 818
Researchers are using exome sequencing and whole-
genome sequencing with increasing frequency to uncover
the causes of genetic disorders. By their very nature, these
tests will find more information than what researchers
sought to find. Over the past year, there has been much
discussion about the return of so-called incidental find-
ings, and the American College of Medical Genetics has
recommended that clinical geneticists actively search for
pathogenic variants in a panel of genes, with the proviso
that patients be offered the ability to ‘‘opt out’’ prior to
testing. Often lost in these discussions are those individ-
uals who undergo sequencing as part of research programs.
It wasn’t long ago that research participants were barred
from learning the results of genetic testing, but the realiza-
tion that positive health decisions could be made on the
basis of these results led to sweeping policy changes.
Now, Jarvik et al., reporting on the behalf of the eMERGE
and CSER consortia, provide recommendations for the re-
turn of results to research participants. In this consensus
statement, the authors stress the differences between
biomedical research and medical care and argue that
although researchers should be prepared to return results
that meet an actionability threshold, they are under no
obligation to search though a pre-set list of variants. The
group also affirms the autonomy of the research partici-
pants and agrees that the ability to ‘‘opt out’’ should be a
requirement of all study designs and that special con-
sideration should be given to studies involving minors.
This is most likely not the last word on this subject, but
it makes an important contribution to an ever-evolving
conversation.Weighing in on Rare Variants
Jiang et al., p. 845
As researchers turn to family-based sequencing studies for
the identification of rare variants associated with various
diseases, methods of teasing out truly causal variants from
benign variants are becoming increasingly important.
Oftentimes, variants that appear to be causal are given
greater weight, and variants that appear benign are given
less weight; choosing this linear combination of variants
is crucial for the accuracy of the association test. Impor-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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likely to have arisen recently, making them more likely to
be population specific. In this study, Jiang et al. integrate
this concept into a rare-variant transmission disequilib-
rium test (rvTDT). To weight causal variants, the authors
compared allele frequencies in the parents of affected chil-
dren to the allele frequency in a control population where
truly causal rare variants should have decreased allele fre-
quency. After these variants were upweighted, the rvTDT
had improved performance over other weightingmethods.
In simulations, the method performed well even with pop-
ulation stratification, although it was best to use a control
population that is similar to the case population. Notably,
this method performs well in the analysis of data to be
collected in the future, and it can also be applied to earlier
exome sequencing studies that might have suffered from
being underpowered. It thus might allow researchers to
uncover new insights from existing data.On the QT: From SNP to Function
Kapoor et al., p. 854
QT intervals that lie outside of the norm are associated
with increased risk of severe cardiovascular events,
including ventricular tachycardia and ventricular fibrilla-
tion. Previous genome-wide association studies (GWASs)
have identified more than 35 loci that contribute to varia-
tion in the QT interval, but just how these SNPs affect the
underlying biology of the QT interval has remained un-
clear. In this issue, Kapoor et al. bring together several lines
of research and propose a functional role for a polymor-
phism in an NOS1AP enhancer. The NOS1AP locus has
consistently been identified as having an association
with the QT interval. The authors therefore began their
search for a functional element by performing deep
sequencing of the region. The main sources of common
variation lay outside of the coding region, and so the
authors performed association analyses of candidate vari-
ants and followed up with a combination of cell biology,
molecular biology, and electrophysiology experiments.
This careful dissection of a GWAS hit highlights the
many types of research that must be undertaken to move
from SNP to function. Moreover, as the authors point
out, such work is just the beginning—there are most likely
several other sites that will play a functional role. And so,
although one chapter has ended, new avenues of research.y of Human Genetics. All rights reserved.
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Seq’ing Insight into 16p11.2 CNVs
Blumenthal et al., p. 870
The finding that copy-number variants (CNVs) underlie
the genetic etiology of autism spectrum disorder (ASD)
has spurred a tremendous amount of research aimed at
understanding how differences in gene dosage affect
neurodevelopment. Reciprocal copy-number variation at
16p11.2 represents one of the most common genetic
causes of ASD, yet many questions remain about duplica-
tions and deletions of this nearly 600 kb region. In this
issue, Blumenthal et al. explore the gene expression
changes that result from 16p11.2 CNVs in humans and
mice. RNA-Seq analysis revealed gene expression alter-
ations both inside and outside of the CNV region, and
integration with available Hi-C data provided evidence
of the physical interactions and alterations in nuclear
architecture that underlie these changes. Notably, the
changes in expression patterns converge on pathways
already implicated in ASD pathogenesis, e.g. chromatin
modification and synaptic function. These findings high-
light the need for researchers to look beyond DNA-level
changes when studying complex disorders such as ASD.
In light of the difficulty in obtaining relevant tissue
from humans, the concordance in findings from human
LCLs and mouse brain tissue is also worth noting, espe-
cially as scientists increase the depth and breadth of
ASD research.802 The American Journal of Human Genetics 94, 801–802, June 5, 2Serine Metabolism Surprise
Shaheen et al., p. 898
Serine is crucial for our survival: this amino acid serves as a
precursor for nucleic acids and amino acids, as well as a
host of other metabolites. It should come as no surprise,
then, that defects in serine production cause health prob-
lems. Indeed, a deficiency of PHGDH, a catalyst in the
rate-limiting step of serine biosynthesis, causes growth
defects and developmental delay. Now, in a surprising
turn of events made possible by the advent of next-gen
sequencing, Shaheen et al. find that a seemingly unrelated
birth defect, Neu-Laxova syndrome (NLS), is also caused by
PHGDHmutations. In contrast to PHGDH deficiency, NLS
is characterized by a wide range of physiological anomalies
and is nearly always lethal in the perinatal period. Meta-
bolic work-ups are infrequent in cases of such early death,
and indeed, there are no reports of such analyses in NLS
cases. The authors were able to examine stored blood
from an affected child, and indeed, serine levels were
abnormally low. As researchers continue to use next-gen
sequencing to uncover the genetic causes of rare diseases,
we will no doubt see additional examples of unexpected
allelic disorders. Such findings should encourage more
frequent interactions between clinicians who were once
viewed as serving vastly different groups of patients and
could suggest therapeutic options for disorders that were
once considered to be untreatable.014
